ClassID:

21256

A61K45/06 - page 7 - CPC Classification

Classification description:

Medicinal preparations containing active ingredients not provided for in groups  -  Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Recent Application in this class:
#1801
20250243457
2025-07-31

MAMMALIAN CELL POPULATION AND MEDICAMENTS FOR CELL THERAPIES IN DOMESTIC ANIMALS AND IMPROVED CELL CULTIVATION METHODS

#1802
20250243293
2025-07-31

COMBINATIONAL TCR-T CELL THERAPY TARGETING TUMOR ANTIGENS, TGF-BETA, AND IMMUNE CHECKPOINTS

#1803
20250243285
2025-07-31

CAR-EXPRESSING CELLS AGAINST MULTIPLE TUMOR ANTIGENS AND USES THEREOF

#1804
20250243267
2025-07-31

COMBINATION OF A GREMLIN-1 ANTAGONIST WITH A CYTIDINE ANALOGUE OR DEOXYCYTIDINE ANALOGUE

#1805
20250243205
2025-07-31

sGC STIMULATORS

#1806
20250243201
2025-07-31

ORGANIC COMPOUNDS

#1807
20250243177
2025-07-31

sGC STIMULATORS

#1808
20250243176
2025-07-31

(S)-1-(1-ACRYLOYLPIPERIDIN-3-YL)-2-FLUORO-5,6,7,8,9,10-HEXAHYDROCYCLO HEPTA[B]INDOLE-4-CARBOXAMIDE, AND RELATED CRYSTALLINE FORMS, COMPOSITIONS, AND METHODS THEREOF

#1809
20250242049
2025-07-31

LIPID COMPOSITION AND METHOD OF DELIVERING THERAPEUTIC AGENT

#1810
20250242046
2025-07-31

ALLOGENEIC HYPOIMMUNE BIOMIMETIC NANOVESICLE FOR THE TREATMENT OF CANCER

#1811
20250242043
2025-07-31

ANTIBODY-DRUG CONJUGATE COMPRISING ANTIBODY AGAINST HUMAN TROP2 AND USE THEREOF

#1812
20250242041
2025-07-31

ANTI-AVB6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

#1813
20250242029
2025-07-31

RAS INHIBITORS

#1814
20250242017
2025-07-31

HISTAMINE AND HRH1 SIGNALING ACTIVITY AS BIOMARKERS AND ASSOCIATED METHODS

#1815
20250242016
2025-07-31

FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE

#1816
20250242012
2025-07-31

GENE DELIVERY SYSTEM

#1817
20250242000
2025-07-31

ANTI-NET COMPOUNDS FOR TREATING AND PREVENTING FIBROSIS AND FOR FACILITATING WOUND HEALING

#1818
20250241988
2025-07-31

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

#1819
20250241980
2025-07-31

TOPICAL ANTIBIOTIC

#1820
20250241971
2025-07-31

EXTRACT OF BETA-GLUCAN-RICH SACCHAROMYCES CEREVISIAE YEAST CELL WALLS IN THE PREVENTION OF THE TOXIC EFFECTS OF MYCOTOXIN DEOXYNIVALENOL (DON)

#1821
20250241968
2025-07-31

COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATION

#1822
20250241948
2025-07-31

Engineered Extracellular Vesicle Delivery Systems and Uses Thereof

#1823
20250241943
2025-07-31

BI-FUNCTIONAL CO-POLYMER USE FOR OPHTHALMIC AND OTHER TOPICAL AND LOCAL APPLICATIONS

#1824
20250241925
2025-07-31

METHODS OF P21 SUPPRESSION FOR BONE REGENERATION AND HEALING

#1825
20250241923
2025-07-31

A DUAL SELECTIVE PI3K DELTA AND GAMMA INHIBITORS AND/OR A SALT-INDUCIBLE KINASE 3 INHIBITOR FOR TREATING SOLID TUMORS

#1826
20250241920
2025-07-31

7-BENZYL-4-(METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[1,2-A]PYRIDO[3,4-E] PYRIMIDIN-5 (1 H)-ONE, SALTS THEREOF AND METHODS OF USING THE SAME IN COMBINATION THERAPY

#1827
20250241917
2025-07-31

SMALL MOLECULE ENHANCERS OF ANTISENSE OLIGO ACTIVITY

#1828
20250241915
2025-07-31

COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS

#1829
20250241903
2025-07-31

TREATMENT OF SYSTOLIC DYSFUNCTION

#1830
20250241896
2025-07-31

L-PAG DERIVATIVES FOR TREATMENT OF SLEEP DISORDERED BREATHING (SDB)

#1831
20250241887
2025-07-31

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

#1832
20250241883
2025-07-31

THERAPEUTIC METHODS USING DECANOIC ACID AND AMINO ACIDS

#1833
20250241869
2025-07-31

COMPOSITIONS AND METHODS COMPRISING DEOXY-PENTITOLS

#1834
20250241858
2025-07-31

METHOD OF DELIVERY OF DNA OR RNA CARGO USING UNSHIELDED LIPID NANOPARTICLES AND COMPOSITIONS THEREOF

#1835
20250241854
2025-07-31

NANOSTRUCTURED LIPID CARRIERS AND STABLE EMULSIONS AND USES THEREOF

#1836
20250236676
2025-07-24

TREATMENT OF SKIN DISEASES OR DISORDERS BY DELIVERY OF ANTI-OSMRBeta ANTIBODY

#1837
20250236675
2025-07-24

Combination Therapies And Patient Stratification With Bispecific Ant-EGFR/C-MET Antibodies

#1838
20250236671
2025-07-24

CD229 Car T Cells And Methods Of Use Thereof

#1839
20250236670
2025-07-24

Antibodies Against Human Siglec-7 and Use Thereof for Immunotherapy

#1840
20250236660
2025-07-24

THERAPEUTIC COMBINATIONS AND METHODS TO TREAT LONG COVID

#1841
20250236658
2025-07-24

PDL2 COMPOUNDS

#1842
20250236632
2025-07-24

BETA-LACTAMASE INHIBITORS

#1843
20250236617
2025-07-24

BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES

#1844
20250236597
2025-07-24

DEUTERATED BENZODIAZEPINE ANALOGS AND METHODS OF USE IN TREATING CANCER

#1845
20250235712
2025-07-24

METHOD FOR THE TREATMENT OF MALARIA

#1846
20250235680
2025-07-24

SYSTEMS AND METHODS FOR IMPROVED PAIN RELIEF FROM STIMULATION OF THERMAL FIBERS

#1847
20250235554
2025-07-24

METHODS FOR IMPROVING ADENO-ASSOCIATED VIRUS (AAV) DELIVERY

#1848
20250235553
2025-07-24

ABHD18 inhibitors

#1849
20250235546
2025-07-24

TREATMENT OF CANCER USING A COMBINATION OF IMMUNOMODULATION AND CHECK POINT INHIBITORS

#1850
20250235518
2025-07-24

Method for preparing tumor vaccine using magnetic thermal inactivation technology

#1851
20250235508
2025-07-24

MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF

#1852
20250235502
2025-07-24

CARDIO-PROTECTIVE EFFECT OF VASOCONSTRICTION-INHIBITING FACTOR (VIF)

#1853
20250235501
2025-07-24

Methods and Compositions for Treating or Preventing Neurological Injury or Neurological Disorders

#1854
20250235489
2025-07-24

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE INTRANASAL SYSTEM

#1855
20250235478
2025-07-24

CHIMERIC ANTIGEN RECEPTOR MODIFIED REGULATORY T CELLS FOR TREATING CANCER

#1856
20250235464
2025-07-24

ANTI-RETROVIRAL THERAPIES AND REVERSE TRANSCRIPTASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE

#1857
20250235458
2025-07-24

Benzimidazole derivatives for use in the treatment or prevention of a histiocytosis or a craniopharyngioma

#1858
20250235456
2025-07-24

METHODS OF USE FOR AZA-QUINAZOLINE COMPOUNDS

#1859
20250235449
2025-07-24

METHODS OF TREATING OCULAR CONDITIONS

#1860
20250235445
2025-07-24

NOVEL PHARMACEUTICAL FORMULATION

#1861
20250235436
2025-07-24

Compositions and Methods for Treatment of Edema

#1862
20250235435
2025-07-24

INHIBITION OF CRYSTAL GROWTH OF ROFLUMILAST

#1863
20250235432
2025-07-24

METHODS OF TREATING CANCERS

#1864
20250235415
2025-07-24

MODULATION OF HUMAN BREAST MILK COMPOSITION

#1865
20250235407
2025-07-24

TAMPER RESISTANT DOSAGE FORMS

#1866
20250235406
2025-07-24

ORAL PRODUCTS AND METHODS OF MANUFACTURE

#1867
20250234882
2025-07-24

DISSOLVABLE-CHEWABLE TABLET

#1868
20250230412
2025-07-17

METHODS AND COMPOSITIONS FOR TREATING CANCER

#1869
20250230252
2025-07-17

TREATMENT FOR ACUTE MYELOID LEUKEMIA WITH ANTI-CD70 ANTIBODIES

#1870
20250230251
2025-07-17

ANTIBODIES TARGETING IL-18 RECEPTOR BETA (IL-18RB) AND RELATED METHODS

#1871
20250230230
2025-07-17

TREATMENT OF PERIVASCULAR FIBROSIS AND OTHER HYPERTENSIVE DISEASES AND CONDITIONS

#1872
20250230218
2025-07-17

PDL1 PEPTIDES FOR USE IN CANCER VACCINES

#1873
20250230213
2025-07-17

PROTEIN TYROSINE-TYROSINE ANALOGS AND METHODS OF USING THE SAME

#1874
20250230188
2025-07-17

METAGENOME-GUIDED BIOSYNTHESIS AND COMPOUNDS AND METHODS OF USE THEREOF

#1875
20250230173
2025-07-17

SALT FORMS OF AN AXL INHIBITOR

#1876
20250230144
2025-07-17

QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

#1877
20250230127
2025-07-17

MONO- OR DI-SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS

#1878
20250228978
2025-07-17

ENGINEERING SUICIDE GENE APPROACHES TO IMPROVE CHEMOTHERAPEUTIC RESPONSE IN CANCER

#1879
20250228968
2025-07-17

TUMOR-INTRINSIC GALECTIN-3 SUPPRESSES MELANOMA METASTASIS

#1880
20250228963
2025-07-17

HYDROGEL PRODRUG FOR TREATMENT

#1881
20250228962
2025-07-17

HYDROGEL PRODRUG FOR TREATMENT

#1882
20250228948
2025-07-17

METHODS OF TREATING OR PREVENTING STENT THROMBOSIS

#1883
20250228946
2025-07-17

ANTI-CD3 ANTIBODY FORMULATIONS

#1884
20250228945
2025-07-17

NEOANTIGENS AND USES THEREOF

#1885
20250228944
2025-07-17

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS

#1886
20250228928
2025-07-17

IMMUNE ENHANCEMENT AND INFECTIOUS DISEASE TREATMENT

#1887
20250228916
2025-07-17

A METHOD OF TREATING OR PREVENTING SEPSIS

#1888
20250228905
2025-07-17

MICROBIAL COMMUNITIES THAT INHIBIT CLOSTRIDIOIDES DIFFICILE AND METHODS OF USING SAME

#1889
20250228903
2025-07-17

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES

#1890
20250228898
2025-07-17

METHODS AND COMPOSITIONS FOR NON-MYELOABLATIVE BONE MARROW RECONSTITUTION

#1891
20250228897
2025-07-17

VAGINAL CARE COMPOSITIONS AND METHODS OF IMPROVING VAGINAL HEALTH

#1892
20250228889
2025-07-17

METHODS AND COMPOSITIONS FOR TREATING HEART CONDITIONS

#1893
20250228884
2025-07-17

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

#1894
20250228882
2025-07-17

ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS

#1895
20250228865
2025-07-17

COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME

#1896
20250228863
2025-07-17

Methods and Products to Screen and Treat Glioblastoma Multiforme and Other Cancers, Including Breast Cancers, Using A Combination of PI3KINASE Inhibitors With Checkpoint Inhibitors

#1897
20250228841
2025-07-17

COMPOSITIONS AFFECTING PIGMENT PRODUCTION AND METHODS FOR TREATMENT OF BACTERIAL DISEASES

#1898
20250228838
2025-07-17

METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS

#1899
20250228834
2025-07-17

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COLON AND LUNG CANCER

#1900
20250228828
2025-07-17

METHODS OF TREATING HEPATIC ENCEPHALOPATHY

#1901
20250228827
2025-07-17

METHODS OF TREATING ERYTHROPOIETIC PROTOPORPHYRIA, X-LINKED PROTOPORPHYRIA, OR CONGENITAL ERYTHROPOIETIC PORPHYRIA WITH GLYCINE TRANSPORT INHIBITORS

#1902
20250228826
2025-07-17

COMBINATION OF A GREMLIN-1 ANTAGONIST WITH AN INHIBITOR OF RAS-RAF-MEK-ERK SIGNALLING

#1903
20250228819
2025-07-17

COMPOSITIONS COMPRISING ATICAPRANT

#1904
20250228817
2025-07-17

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

#1905
20250228816
2025-07-17

ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS

#1906
20250228813
2025-07-17

METHODS OF ADMINISTRATION FOR HIGHLY WATER-SOLUBLE SALTS OF A SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKER

#1907
20250228805
2025-07-17

PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY

#1908
20250228793
2025-07-17

2,4-Dinitrophenol Formulations and Methods Using Same

#1909
20250228792
2025-07-17

WATER-BASED FORMULATION OF DISCREET LIQUID PATCH FOR THE PAIN-FREE TREATMENT OF COLD SORES

#1910
20250228790
2025-07-17

PARTICLES COMPRISING A THERAPEUTIC OR DIAGNOSTIC AGENT AND SUSPENSIONS AND METHODS OF USE THEREOF

#1911
20250228777
2025-07-17

COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS

#1912
20250228767
2025-07-17

COMPOSITIONS AND METHODS FOR DRUG INSTILLATION INTO THE URINARY BLADDER

#1913
20250223599
2025-07-10

PREPARATION AND ANTI-TUMOR APPLICATION OF GENE THERAPY VECTOR INTERFERING CKLF-LIKE MARVEL TRANSMEMBRANE DOMAIN-CONTAINING PROTEIN 6 (CMTM6) EXPRESSION

#1914
20250223371
2025-07-10

EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS

#1915
20250223366
2025-07-10

MONOCLONAL ANTIBODIES AND BISPECIFIC ANTIBODY AGAINST C-MET

#1916
20250223358
2025-07-10

NOVEL ANTI-CD3 ANTIBODIES AND USES THEREOF

#1917
20250223348
2025-07-10

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

#1918
20250223329
2025-07-10

BIFUNCTIONAL FUSION PROTEIN COMPOSED OF IL-15 AND ANTIBODY AGAINST T CELL CO-STIMULATORY MOLECULE

#1919
20250223328
2025-07-10

TRUNCATED DOMINANT NEGATIVE CEBPB AND CEBPD PROTEINS AND METHODS OF USE FOR DECREASING VIABILITY OF NEOPLASTIC CELLS

#1920
20250223311
2025-07-10

MINIMAL SAPONIN ANALOGUES, SYNTHESIS AND USE THEREOF

#1921
20250223303
2025-07-10

TRICYCLIC BORONIC ACID DERIVATIVE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#1922
20250223289
2025-07-10

INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN

#1923
20250223265
2025-07-10

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

#1924
20250223256
2025-07-10

METHODS FOR MAKING AND USING ENDOXIFEN

#1925
20250222144
2025-07-10

COMPOSITIONS AND METHODS FOR TARGETED TREATMENT AND IMAGING OF CANCER TUMORS

#1926
20250222127
2025-07-10

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING TRANSPLANT-ASSOCIATED INJURY

#1927
20250222118
2025-07-10

Beta-Lactam-Cannabinoid Conjugate Molecules

#1928
20250222101
2025-07-10

Composition and Methods for Preventing and Treating African Swine Fever in Wild and Domestic Swine

#1929
20250222090
2025-07-10

TUBERCULOSIS VACCINES

#1930
20250222069
2025-07-10

METHODS AND COMPOSITIONS FOR TREATING MYELOFIBROSIS

#1931
20250222050
2025-07-10

Chlorella and Corn Leaf Extract Compositions, Their Production, and Methods of Use

#1932
20250222046
2025-07-10

COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER USING COMBINED THERAPY, COMPRISING LACTOBACILLUS PLANTARUM STRAIN AND ANTICANCER DRUG

#1933
20250222035
2025-07-10

PROCESSES FOR MAKING AND USING A MESENCHYME STEM CELL SECRETOME FOR LIMBAL STEM CELL DEFICIENCY (LSCD) TREATMENT

#1934
20250222031
2025-07-10

Treatment of Disc Degeneration using B Regulatory Cells

#1935
20250222024
2025-07-10

METHOD AND COMPOSITION FOR TREATING CORONA VIRUS, INFLUENZA, AND ACUTE RESPIRATORY DISTRESS SYNDROME

#1936
20250222020
2025-07-10

ORAL COMPOSITION CONTAINING DIMETHYLGLYCINE FOR IMPROVING THE CONDITION OF THE HAIR AND SCALP

#1937
20250222018
2025-07-10

METHODS OF USING AVERMECTIN COMPOSITIONS FOR THE TREATMENT OF PAIN AND DOSING REGIMENS

#1938
20250221999
2025-07-10

Methods for Treating Immune Thrombocytopenia by Administering (R)-2-[3-[4-Amino-3-(2-Fluoro-4-Phenoxy- Phenyl) Pyrazolo[3,4-D]Pyrimidin-1-YL]Piperidine-1-Carbonyl]-4-Methyl-4-[4-(Oxetan-3-YL)Piperazin-1-YL]Pent-2-Enenitrile

#1939
20250221992
2025-07-10

Methods Of Treating Depression Using Orexin-2 Receptor Antagonists

#1940
20250221967
2025-07-10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER AND OTHER PROLIFERATIVE DISEASES

#1941
20250221962
2025-07-10

FABP4 AS A THERAPEUTIC TARGET IN SKIN DISEASES

#1942
20250221961
2025-07-10

Pharmaceutical Combinations For The Treatment Of Cancer

#1943
20250221957
2025-07-10

PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS

#1944
20250221951
2025-07-10

INTRANASAL ADMINISTRATION OF N-ACETYLCYSTEINE AND USES THEREOF

#1945
20250221947
2025-07-10

METHODS FOR TREATING A CORONAVIRUS INFECTION USING VALPROIC ACID AND DOCOSAHEXAENOIC ACID

#1946
20250221932
2025-07-10

IMMUNE ENHANCEMENT OF CANCER TREATMENT

#1947
20250221923
2025-07-10

BOOSTING OSMOTIC BLOOD-ORGAN BARRIER OPENING FOR IMPROVED DELIVERY OF THERAPEUTICS TO ORGANS

#1948
20250215506
2025-07-03

INTEGRATION OF TUMOR CHARACTERISTICS WITH BREAST CANCER INDEX

#1949
20250215486
2025-07-03

LIVER PROTECTIVE MARC VARIANTS AND USES THEREOF

#1950
20250215435
2025-07-03

ANTI-HELICASE THERAPY FOR TREATMENT OF REPEAT EXPANSION DISEASE

#1951
20250215431
2025-07-03

METHOD OF TREATING CHRONIC HEPATITIS B

#1952
20250215429
2025-07-03

COMPOSITION AND METHOD FOR INHIBITING ANGIOTENSINOGEN (AGT) PROTEIN EXPRESSION

#1953
20250215411
2025-07-03

FUSION PROTEINS AND USES THEREOF

#1954
20250215396
2025-07-03

COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES

#1955
20250215101
2025-07-03

DR5 Agonist and PLK1 Inhibitor or CDK Inhibitor Combination Therapy

#1956
20250215090
2025-07-03

COMPOSITIONS AND METHODS FOR TREATING IMMUNE THROMBOCYTOPENIA

#1957
20250215087
2025-07-03

COMBINATION THERAPY OF KRAS INHIBITOR AND TREG DEPLETING AGENT

#1958
20250215086
2025-07-03

ANTI-PD-1 ANTIBODY FORMULATIONS

#1959
20250215079
2025-07-03

ANTIBODIES SPECIFICALLY BINDING PD-1, TIM-3 OR PD-1 AND TIM-3 AND THEIR USES

#1960
20250215076
2025-07-03

COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA

#1961
20250215072
2025-07-03

ISOFORM-SELECTIVE TGFB1 INHIBITORS AND USE THEREOF

#1962
20250215053
2025-07-03

LYSINE RICH CELL-PENETRATING PEPTIDES

#1963
20250215039
2025-07-03

NUCLEOSIDES FOR TREATING CANCER

#1964
20250215031
2025-07-03

CRYSTALLINE FORMS OF TENOFOVIR ALAFENAMIDE

#1965
20250215013
2025-07-03

SUBSTITUTED TRICYCLIC COMPOUNDS AS PARP INHIBITORS AND THE USE THEREOF

#1966
20250214996
2025-07-03

SALTS AND SOLID FORMS OF AN ESTROGEN RECEPTOR ANTAGONIST

#1967
20250214989
2025-07-03

NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER

#1968
20250214985
2025-07-03

MACROCYCLIC COMPLEXES OF ALPHA-EMITTING RADIONUCLIDES AND THEIR USE IN TARGETED RADIOTHERAPY OF CANCER

#1969
20250214964
2025-07-03

COMPOUNDS DERIVED FROM 4-AMINO-N-(4-AMINOPHENYL) BENZAMIDE AND ANALOGUES AND USE THEREOF

#1970
20250214962
2025-07-03

PYRIDINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV INFECTED CELLS

#1971
20250214942
2025-07-03

INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE

#1972
20250214930
2025-07-03

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

#1973
20250213881
2025-07-03

METHODS TO MITIGATE SIDE EFFECTS OF CANCER TREATMENTS

#1974
20250213731
2025-07-03

TREATING METASTATIC CANCER AND MODEL SYSTEMS FOR METASTATIC DISEASE

#1975
20250213724
2025-07-03

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

#1976
20250213721
2025-07-03

COMPOSITIONS INCLUDING IFNE AND USES THEREOF

#1977
20250213688
2025-07-03

METHODS AND COMPOSITIONS FOR LOCALIZED PRODUCTION AND DELIVERY OF BIOLOGICAL MOLECULES

#1978
20250213685
2025-07-03

ANTI-EGFR ANTIBODY DRUG CONJUGATES

#1979
20250213684
2025-07-03

COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO TIM-3

#1980
20250213681
2025-07-03

NOVEL APPROACH FOR TREATMENT OF CANCER USING IMMUNOMODULATION

#1981
20250213665
2025-07-03

METHODS FOR INHIBITING TRAINED IMMUNITY WITH NANOBIOLOGIC COMPOSITIONS

#1982
20250213661
2025-07-03

ENHANCED DELIVERY OF ANTIOXIDANTS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS INVOLVING OXIDATIVE STRESS

#1983
20250213654
2025-07-03

PEPTIDES AND METHODS FOR USE IN TREATING PAIN

#1984
20250213647
2025-07-03

CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE

#1985
20250213641
2025-07-03

COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF

#1986
20250213627
2025-07-03

RECOMBINANT MICROORGANISM-BASED METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASE

#1987
20250213616
2025-07-03

COMPOSITIONS AND METHODS FOR TREATING A REFRACTORY OR RELAPSED CANCER OR A CHRONIC INFECTIOUS DISEASE

#1988
20250213608
2025-07-03

VANADYL SULFATE COMPOSITIONS AND METHODS OF USE THEREFOR FOR THE TREATEMENT AND PREVENTION OF AGING-RELATED DISEASES AND CANCER

#1989
20250213603
2025-07-03

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER

#1990
20250213602
2025-07-03

PHARMACEUTICAL COMPOSITIONS FOR DEMODEX RELATED BLEPHARITIS AND EYELID CRUSTING

#1991
20250213593
2025-07-03

Use of Derivatives based on Sarsasapogenin Structure and Pharmaceutical Compositions thereof

#1992
20250213592
2025-07-03

PHARMACEUTICAL COMPOSITION COMPRISING CURCUMIN AND GINSENOSIDE, AND FORMULATION THEREOF

#1993
20250213579
2025-07-03

COMBINATION THERAPIES

#1994
20250213578
2025-07-03

ALPHA POLYGLUTAMATED AMINOPTERIN AND USES THEREOF

#1995
20250213569
2025-07-03

METHODS AND COMPOSITIONS FOR MEASURING AND INHIBITING EXONUCLEASE ACTIVITY

#1996
20250213564
2025-07-03

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEUROGENERATIVE DISEASE

#1997
20250213559
2025-07-03

COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CYTOKINE RELEASE SYNDROME

#1998
20250213544
2025-07-03

ALK5 INHIBITORS AS SKELETAL MUSCLE HYPERTROPHY INDUCERS

#1999
20250213524
2025-07-03

COMPOSITIONS FOR USE

#2000
20250213523
2025-07-03

COMBINATION OF HDAC INHIBITORS AND STATINS FOR USE IN THE TREATMENT OF PANCREATIC CANCER

#2001
20250213522
2025-07-03

LYMPH DIRECTING PRODRUGS

#2002
20250213519
2025-07-03

SYNERGY FOR INCREASING INSULIN SENSITIVITY

#2003
20250213515
2025-07-03

METHODS FOR THE TREATMENT OF GLIOBLASTOMA MULTIFORME

#2004
20250213511
2025-07-03

BACTERICIDAL AND VIRUCIDAL PHARMACEUTICAL COMPOSITION

#2005
20250213488
2025-07-03

SYNTHETIC PROGESTOGENS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

#2006
20250213487
2025-07-03

SYNTHETIC PROGESTOGENS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

#2007
20250213482
2025-07-03

OXYGEN-ENHANCED ADAPTIVE FUNCTIONAL BEVERAGE FOR ANTI-AGING AND METHOD OF PREPARATION

#2008
20250213465
2025-07-03

SYNTHETIC TRANSDERMAL CANNABIDIOL FOR THE TREATMENT OF FOCAL EPILEPSY IN ADULTS

#2009
20250207135
2025-06-26

COMPOUNDS AND COMPOSITIONS INCLUDING PHOSPHOROTHIOATED OLIGODEOXYNUCLEOTIDE, AND METHODS OF USE THEREOF

#2010
20250207093
2025-06-26

MAMMALIAN CELL POPULATION AND MEDICAMENTS FOR CELL THERAPIES IN HUMANS AND IMPROVED CELL CULTIVATION METHODS

#2011
20250206838
2025-06-26

THERAPEUTIC INHIBITION OF CD38 TO TREAT HIDRADENITIS SUPPURATIVA

#2012
20250206791
2025-06-26

USE OF IRE1ALPHA-XBP1 SIGNALING PATHWAY BIOMARKERS FOR MODULATING IMMUNE RESPONSES

#2013
20250206779
2025-06-26

ANGIOTENSIN-(1-9) ANALOGUE BASED ON D AMINO ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

#2014
20250206774
2025-06-26

C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS

#2015
20250206742
2025-06-26

NLRP3 INFLAMMASOME INHIBITORS

#2016
20250206725
2025-06-26

MODULATORS OF THR-BETA AND METHODS OF USE THEREOF

#2017
20250206724
2025-06-26

SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS

#2018
20250206722
2025-06-26

SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS

#2019
20250205429
2025-06-26

PORTABLE DRUG MIXING AND DELIVERY DEVICE AND ASSOCIATED METHODS

#2020
20250205358
2025-06-26

PHOTOACTIVATABLE NANOPARTICLES AND USES THEREOF AS AGENTS FOR IMMUNOTHERAPY COMBINATIONS

#2021
20250205355
2025-06-26

METHODS AND SYSTEMS FOR APPLICATIONS INVOLVING ANTIGEN-PRESENTING CELLS

#2022
20250205343
2025-06-26

BI-FUNCTIONAL MOLECULES TO DEGRADE CIRCULATING PROTEINS

#2023
20250205333
2025-06-26

COMBINATION THERAPY OF AN ANTI CD20 ANTIBODY WITH A BTK INHIBITOR

#2024
20250205332
2025-06-26

METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS

#2025
20250205319
2025-06-26

SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION

#2026
20250205318
2025-06-26

ARGINASE1 POLYPEPTIDES

#2027
20250205316
2025-06-26

COLLOIDAL FIBRIN NANOPARTICLE COMPOSITIONS AND USES

#2028
20250205313
2025-06-26

NONPOLYMERIZABLE FIBRINOGEN AS AN ANTITHROMBOTIC AGENT

#2029
20250205300
2025-06-26

PLANT-BASED COMPOSITIONS AND METHODS FOR HORMONE SIGNALING, BLOOD GLUCOSE CONTROL, APPETITE CONTROL, AND WEIGHT MANAGEMENT

#2030
20250205290
2025-06-26

USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

#2031
20250205286
2025-06-26

COMPOSITIONS, REAGENTS, AND METHODS FOR TREATING PITT-HOPKINS SYNDROME

#2032
20250205274
2025-06-26

FORMULATIONS FOR TREATMENT OF XEROSTOMIA, AND METHODS THEREFOR

#2033
20250205271
2025-06-26

MICRORNAS FOR INHIBITING THE EXPRESSION OF TRF2 IN TUMORS

#2034
20250205265
2025-06-26

ASPERULOSIDE AS AN AGENT FOR IMPROVING VASCULAR AND METABOLIC FUNCTION IN OBESITY: ROLE OF NRF2 ACTIVATION

#2035
20250205252
2025-06-26

7-KETOLITHOCHOLIC ACID FOR USE IN THE TREATMENT OF GUT DYSBIOSIS AND AS A PREBIOTIC

#2036
20250205240
2025-06-26

COMBINATIONS

#2037
20250205237
2025-06-26

METHODS OF TREATING DISORDERS USING CSF1R INHIBITORS

#2038
20250205235
2025-06-26

DOSE REGIMEN FOR VERICIGUAT

#2039
20250205209
2025-06-26

Methods of Treating a Subject for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Compositions for Use in The Same

#2040
20250205205
2025-06-26

METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING FIBROSIS AND IMPROVING FUNCTIONAL RECOVERY AFTER INJURY OR WITH AGING

#2041
20250205188
2025-06-26

TREATMENT OR PREVENTION OF RESPIRATORY DISEASES CHARACTERISED BY, OR INVOLVING, LUNG FIBROSIS

#2042
20250205180
2025-06-26

METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS

#2043
20250205170
2025-06-26

DELMOPINOL AND DELMOPINOL SALT CONTAINING NANOPARTICLES AND USES THEREOF

#2044
20250205163
2025-06-26

ENGINEERED EXTRACELLULAR VESICLES FOR TARGETED DRUG DELIVERY TO MUSCLE

#2045
20250205155
2025-06-26

FORMULATIONS COMPRISING MELPHALAN FLUFENAMIDE AND CYCLODEXTRIN

#2046
20250204515
2025-06-26

Heparanase Inhibition for Graft Protection

#2047
20250201406
2025-06-19

METHOD AND BIOMARKER FOR PREDICTING SEVERITY OF COVID-19 DISEASE AND METHOD FOR THERAPEUTIC INTERVENTION IN COVID-19 DISEASE

#2048
20250197837
2025-06-19

SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF

#2049
20250197836
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

#2050
20250197835
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

#2051
20250197834
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

#2052
20250197833
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

#2053
20250197832
2025-06-19

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

#2054
20250197520
2025-06-19

HIGHLY CONCENTRATED PHARMACEUTICAL FORMULATIONS

#2055
20250197516
2025-06-19

HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL-4 RECEPTOR

#2056
20250197513
2025-06-19

OSMR-SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF THEIR USE

#2057
20250197512
2025-06-19

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

#2058
20250197498
2025-06-19

METHODS FOR IN VIVO EXPANSION OF CD8+ T CELLS AND PREVENTION OR TREATMENT OF GVHD

#2059
20250197477
2025-06-19

PROCESSES FOR MAKING AND USING A CELLULAR FIBRONECTIN COMPOSITION

#2060
20250197463
2025-06-19

TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF NEBULIZED mRNA ENCODING CFTR

#2061
20250197421
2025-06-19

MCL1 INHIBITORS

#2062
20250197418
2025-06-19

Polymorphic Compounds And Uses Thereof

#2063
20250197410
2025-06-19

COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS

#2064
20250197406
2025-06-19

INDAZOLES AS HEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) INHIBITORS AND METHODS FOR USING SAME

#2065
20250197377
2025-06-19

NOVEL PHARMACEUTICAL SALTS AND POLYMORPHIC FORMS OF AN ERBB AND BTK INHIBITOR

#2066
20250197376
2025-06-19

PYRAZINE AMIDE DERIVATIVES

#2067
20250197355
2025-06-19

TEAD Targeting Compounds and Methods Thereof

#2068
20250197342
2025-06-19

METHOD OF TREATING OCULAR DISORDERS WITH COMPOUNDS FOUND IN HARDERIAN GLAND SECRETIONS

#2069
20250196140
2025-06-19

MICRO- AND NANO-FLUIDIC CHIP, METHOD OF FABRICATING THE SAME, AND APPLICATIONS THEREOF

#2070
20250196139
2025-06-19

MICRO- AND NANO-FLUIDIC CHIP, METHOD OF FABRICATING THE SAME, AND APPLICATIONS THEREOF

#2071
20250195686
2025-06-19

D GLUTAMATE POLYGLUTAMATED ANTIFOLATES AND USES THEREOF

#2072
20250195672
2025-06-19

DENDRIMER COMPOSITIONS FOR TARGETED DELIVERY OF THERAPEUTICS TO NEURONS

#2073
20250195662
2025-06-19

RAS INHIBITORS

#2074
20250195648
2025-06-19

THERAPEUTIC COMPOSITION AND METHOD COMBINING MULTIPLEX IMMUNOTHERAPY WITH CANCER VACCINE FOR THE TREATMENT OF CANCER

#2075
20250195644
2025-06-19

Compositions For and Methods of Preventing Metastases

#2076
20250195641
2025-06-19

IMMUNOTHERAPEUTIC CONSTRUCTS AND METHODS OF THEIR USE

#2077
20250195630
2025-06-19

COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR TREATMENT OF GRAFT VERSUS HOST DISEASE

#2078
20250195628
2025-06-19

ANALYTICAL METHOD AND THERAPEUTICAL AGENT FOR USE IN COMBINATION WITH L-ASPARAGINASE IN TUMOUR THERAPY

#2079
20250195622
2025-06-19

METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY

#2080
20250195619
2025-06-19

USES OF PTHRP ANALOGUE IN REDUCING FRACTURE RISK

#2081
20250195609
2025-06-19

USE OF ANNEXINS IN PREVENTING AND TREATING CARDIAC NEURONAL CELL MEMBRANE INJURY AND DISEASE

#2082
20250195608
2025-06-19

Therapeutic Compositions for the Treatment of Dry Eye Disease

#2083
20250195603
2025-06-19

COMPOSITION FOR PREVENTING OR TREATING DENTAL CARIES

#2084
20250195602
2025-06-19

Compositions and Methods for Treating Neuropathy

#2085
20250195565
2025-06-19

Pharmaceutical Composition for Postpartum Recovery and Treatment of Pelvic Floor Dysfunction

#2086
20250195547
2025-06-19

COMPOSITIONS AND METHODS OF TREATMENT FOR CONGENITAL DIARRHEAL DISORDER

#2087
20250195538
2025-06-19

BETULIN-CONTAINING BIRCH BARK EXTRACTS AND THEIR FORMULATION

#2088
20250195528
2025-06-19

DOSE REGIMEN OF VICASINABIN

#2089
20250195527
2025-06-19

METHODS FOR TREATING TESTICULAR AND OVARIAN ADRENAL REST TUMORS

#2090
20250195525
2025-06-19

ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OF SYSTEMIC DISEASES IN CATS

#2091
20250195520
2025-06-19

COMBINATION THERAPY USING A PTPN11 INHIBITOR AND AN EGFR INHIBITOR

#2092
20250195514
2025-06-19

METHODS OF TREATING CHOLANGIOCARCINOMA

#2093
20250195505
2025-06-19

USE OF DEXTROMETHORPHAN IN COMBINATION WITH CYP2D6 AND CYP3A4 ENZYME INHIBITORS FOR THE TREATMENT OF PAIN

#2094
20250195492
2025-06-19

USE OF IPTACOPAN FOR THE TREATMENT OF LUPUS NEPHRITIS

#2095
20250195488
2025-06-19

MEDICINE CONTAINING VITAMIN D DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, USED IN COMBINATION WITH IMMUNOMODULATORY SUBSTANCE

#2096
20250195480
2025-06-19

MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS

#2097
20250195474
2025-06-19

Piezo Inhibition for Wound Healing

#2098
20250195471
2025-06-19

ASYMMETRIC ALLYL TRYPTAMINES

#2099
20250195470
2025-06-19

FORMULATIONS COMPRISING TRIPTAN COMPOUNDS

#2100
20250195468
2025-06-19

METHODS AND COMPOSITIONS FOR TREATING COLORECTAL CANCER WITH INDOXYL SULFATE